Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: a novel therapeutic strategy. Here, CD274 is linked to peripheral T-cell lymphoma, not otherwise specified.